Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 11 citing articles:

The ISoP PatEG-SIG for Promoting Patient Engagement in Pharmacovigilance: A Change of Paradigm is Needed
Manal M. Younus, Mayada Alkhakany, Priya Bahri, et al.
Drug Safety (2023) Vol. 46, Iss. 7, pp. 619-623
Open Access | Times Cited: 8
Factors Contributing to Best Practices for Patient Involvement in Pharmacovigilance in Europe: A Stakeholder Analysis
Monica van Hoof, Katherine Chinchilla, Linda Härmark, et al.
Drug Safety (2022) Vol. 45, Iss. 10, pp. 1083-1098
Open Access | Times Cited: 12
The STAR Compass to Guide Future Pharmacovigilance Based on a 10-Year Review of the Strengthened EU System
Priya Bahri, Georgy Genov, Peter Arlett, et al.
Drug Safety (2024) Vol. 47, Iss. 10, pp. 941-956
Open Access | Times Cited: 2
Communicating for the Safe Use of Medicines: Progress and Directions for the 2020s Promoted by the Special Interest Group of the International Society of Pharmacovigilance
Priya Bahri, Geoffrey Bowring, Brian Edwards, et al.
Drug Safety (2023) Vol. 46, Iss. 6, pp. 517-532
Open Access | Times Cited: 5
Patient and Public Involvement in Pharmacovigilance
Florence van Hunsel, Manal M. Younus, Anthony R. Cox
Springer eBooks (2024), pp. 273-293
Closed Access | Times Cited: 1
Challenges in the Implementation of EU Risk Minimisation Measures for Medicinal Products in Clinical Practice Guidelines: Mixed Methods Multi-Case Study
Mathias Møllebæk, Helga Gardarsdóttir, Alexia Bikou, et al.
Drug Safety (2024) Vol. 48, Iss. 2, pp. 161-177
Open Access | Times Cited: 1
A Qualitative Study of Stakeholders’ Views on Pharmacovigilance System, Policy, and Coordination in Pakistan
Muhammad Akhtar Abbas Khan, Saima Hamid, Shahzad Ali Khan, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 7
Active Pharmacovigilance Study: A Follow-Up Model of Oral Anti-Cancer Drugs under Additional Monitoring
Sofia Pinto Carvalho da Silva, Mafalda Jesus, Fátima Roque, et al.
Current Oncology (2023) Vol. 30, Iss. 4, pp. 4139-4152
Open Access | Times Cited: 3
Promoting Collaboration of Regulators and Patients in Improving Drug Safety and Regulatory Decision Making
Yoong Khean Khoo, John C. W. Lim, Wei Chuen Tan‐Koi, et al.
Drug Safety (2023) Vol. 47, Iss. 3, pp. 217-225
Closed Access | Times Cited: 2
Collaborative Approaches to Establishing and Implementing Pharmacovigilance Systems
Brian Edwards, Angela Caro
Springer eBooks (2024), pp. 295-317
Closed Access
Exploring the social dimensions of microbial food safety risk governance
Charlie Van Paepeghem, Liesbeth Jacxsens, Wim Verbeke, et al.
Trends in Food Science & Technology (2024) Vol. 154, pp. 104789-104789
Closed Access
Page 1

Scroll to top